Rona D. Yaeger
Impact in
- Oncology top 0.05%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 117
- Colorectal Cancer Treatments and Studies 76
- Colorectal Cancer Surgical Treatments 19
- Cancer Treatment and Pharmacology 11
-
- Genetic factors in colorectal cancer 48
- Co-authors
- Ryan Bruce Corcoran (3 shared papers)David Solit (13 shared papers)Leonard B. Saltz (24 shared papers)Neal X. Rosen (10 shared papers)Andrea Cercek (26 shared papers)Efsevia Vakiani (13 shared papers)Nancy E. Kemeny (10 shared papers)Jaclyn Frances Hechtman (17 shared papers)
- Journals
- Annals of Oncology (22 papers)Clinical Cancer Research (18 papers)Cancer Discovery (14 papers)Journal of Clinical Oncology (13 papers)Nature Medicine (9 papers)
- Partner nations
- United StatesItalyJapan
In The Last Decade
Rona D. Yaeger
189 papers receiving 25.7k citations
Rona D. Yaeger's Hit Papers
Peers
Comparison fields: 5 of 146
- Oncology 13.3k
- Cancer Research 6.5k
- Pathology and Forensic Medicine 4.9k
- Pulmonary and Respiratory Medicine 5.0k
- Hepatology 797
Countries citing papers authored by Rona D. Yaeger
This map shows the geographic impact of Rona D. Yaeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rona D. Yaeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rona D. Yaeger more than expected).
Fields of papers citing papers by Rona D. Yaeger
This network shows the impact of papers produced by Rona D. Yaeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rona D. Yaeger. The network helps show where Rona D. Yaeger may publish in the future.
Co-authors
The 25 scholars most cited alongside Rona D. Yaeger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 202 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor mutational load predicts survival after immunotherapy across multiple cancer types Hit paper breakdown → | 2019 | 3019 |
| 2 | Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients Hit paper breakdown → | 2017 | 2650 |
| 3 | OncoKB: A Precision Oncology Knowledge Base Hit paper breakdown → | 2017 | 1972 |
| 4 | Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer Hit paper breakdown → | 2012 | 1586 |
| 5 | Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer Hit paper breakdown → | 2019 | 1117 |
| 6 | PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer Hit paper breakdown → | 2022 | 1083 |
| 7 | Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer Hit paper breakdown → | 2018 | 668 |
| 8 | Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy Hit paper breakdown → | 2022 | 596 |
| 9 | Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E-Mutant Colorectal Cancer Hit paper breakdown → | 2018 | 492 |
| 10 | Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer Hit paper breakdown → | 2018 | 484 |
| 11 | Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer Hit paper breakdown → | 2018 | 477 |
| 12 | Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS Hit paper breakdown → | 2017 | 437 |
| 13 | Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy Hit paper breakdown → | 2019 | 429 |
| 14 | A rectal cancer organoid platform to study individual responses to chemoradiation Hit paper breakdown → | 2019 | 423 |
| 15 | Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients Hit paper breakdown → | 2022 | 418 |
| 16 | Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study Hit paper breakdown → | 2021 | 395 |
| 17 | EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer Hit paper breakdown → | 2020 | 391 |
| 18 | Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C Hit paper breakdown → | 2022 | 369 |
| 19 | Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer Hit paper breakdown → | 2022 | 358 |
| 20 | 2019 | 342 |
About Rona D. Yaeger
Rona D. Yaeger is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 202 papers that have together received 26.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (76 papers), Genetic factors in colorectal cancer (48 papers), Cancer Genomics and Diagnostics (32 papers), Melanoma and MAPK Pathways (32 papers), Lung Cancer Treatments and Mutations (24 papers), Colorectal Cancer Surgical Treatments (19 papers), Colorectal and Anal Carcinomas (12 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Oncology (13.3k citations), Cancer Research (6.5k citations), Pathology and Forensic Medicine (4.9k citations), Pulmonary and Respiratory Medicine (5.0k citations) and Hepatology (797 citations). Rona D. Yaeger has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Ryan Bruce Corcoran, David Solit, Leonard B. Saltz, Neal X. Rosen, Andrea Cercek, Efsevia Vakiani, Nancy E. Kemeny, Jaclyn Frances Hechtman, Tanios S. Bekaii-Saab and Marinela Capanu. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, Cancer Discovery, Journal of Clinical Oncology and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.